2026 ICD-10-CM Diagnosis Code Z13.220Encounter for screening for lipoid disorders
Z13.220 is a billable ICD-10-CM diagnosis code for encounter for screening for lipoid disorders. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Encounter for observation and examination for conditions ruled out (excludes infectious disease, neoplasm, mental disorders).
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for Z13.220.
Present on Admission (POA)Billing
Z13.220 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Encounter for screening for cholesterol level
- Encounter for screening for hypercholesterolemia
- Encounter for screening for hyperlipidemia
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- screening for - Z13.220
- Screening (for) - Z13.9
- nutritional - Z13.21
- lipoid disorders - Z13.220
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Cholesterol
- elevated (high)
- screening for
- Screening(for)
- disease or disorder
- nutritional
- metabolic
- lipoid disorders
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Health Screening
Screenings are tests that look for diseases before you have symptoms. Screening tests can find diseases early, when they're easier to treat. You can get some screenings in your doctor's office. Others need special equipment, so you may need to go to a different office or clinic.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Z13.220 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Z13.220Overview
Is Z13.220 (Encounter for screening for metabolic disorder) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report encounter for screening for lipoid disorders on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Can Z13.220 be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because encounter for screening for lipoid disorders describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Is Z13.220 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for encounter for screening for lipoid disorders on inpatient claims.
What is the ICD-9 equivalent of Z13.220?
Under the General Equivalence Mappings, encounter for screening for lipoid disorders converts to ICD-9-CM V77.91 (screen lipoid disorders). The mapping is a direct match.
